{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:18:12Z","timestamp":1782951492072,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.lanwpc.2025.101492","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T15:43:45Z","timestamp":1739029425000},"page":"101492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The Holy Grail: highlighting the need for equitable access to dementia treatments and clinical trials"],"prefix":"10.1016","volume":"55","author":[{"given":"Rebekah M.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Piguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J.","family":"Mummery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Naismith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muireann","family":"Irish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10248","key":"10.1016\/j.lanwpc.2025.101492_bib1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.lanwpc.2025.101492_bib2","series-title":"Dementia in the Asia Pacific Region","year":"2014"},{"issue":"4","key":"10.1016\/j.lanwpc.2025.101492_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-007409","article-title":"The economic burden of dementia in low- and middle-income countries (LMICs): a systematic review","volume":"7","author":"Mattap","year":"2022","journal-title":"BMJ Glob Health"},{"issue":"20","key":"10.1016\/j.lanwpc.2025.101492_bib4","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1212\/WNL.0000000000004614","article-title":"The\u00a0social and economic burden of frontotemporal degeneration","volume":"89","author":"Galvin","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.lanwpc.2025.101492_bib5","article-title":"The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint","volume":"29","author":"Jonsson","year":"2023","journal-title":"Lancet Reg Health Eur"},{"issue":"19","key":"10.1016\/j.lanwpc.2025.101492_bib6","doi-asserted-by":"crossref","first-page":"e1837","DOI":"10.1212\/WNL.0000000000207770","article-title":"Eligibility for anti-amyloid treatment in a population-based study of cognitive aging","volume":"101","author":"Pittock","year":"2023","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.lanwpc.2025.101492_bib7","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/jnnp-2024-333468","article-title":"Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer's disease","volume":"95","author":"Dobson","year":"2024","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lanwpc.2025.101492_bib8","series-title":"Equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer","author":"Australia","year":"2024"},{"issue":"6","key":"10.1016\/j.lanwpc.2025.101492_bib9","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101492_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.lanwpc.2025.101492_bib11","article-title":"Is Australia ready for the rollout of amyloid-targeting therapies for Alzheimer's disease? Results from a national survey characterising current infrastructure capability, workforce and training needs of memory and cognition clinics","volume":"7","author":"Michaelian","year":"2024","journal-title":"medRxiv"},{"issue":"8","key":"10.1016\/j.lanwpc.2025.101492_bib12","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: alzheimer's Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.lanwpc.2025.101492_bib13","article-title":"Risk factors for the neurodegenerative dementias in the Western Pacific region","volume":"50","author":"Clarke","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"issue":"6","key":"10.1016\/j.lanwpc.2025.101492_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5694\/mja2.51880","article-title":"Assessing preparedness for Alzheimer disease-modifying therapies in Australasian health care systems","volume":"218","author":"Brodtmann","year":"2023","journal-title":"Med J Aust"},{"issue":"10","key":"10.1016\/j.lanwpc.2025.101492_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/gps.6157","article-title":"Projected annual lecanemab treatment eligibility in an Irish regional specialist memory clinic","volume":"39","author":"Connolly","year":"2024","journal-title":"Int J Geriatr Psychiatry"},{"issue":"7","key":"10.1016\/j.lanwpc.2025.101492_bib16","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1002\/alz.12995","article-title":"A\u00a0call for clinical trial globalization in Alzheimer's disease and related dementia","volume":"19","author":"Llibre-Guerra","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"7","key":"10.1016\/j.lanwpc.2025.101492_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.14606","article-title":"Inclusion of underrepresented groups in preclinical alzheimer disease trials-opportunities abound","volume":"4","author":"Manly","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.lanwpc.2025.101492_bib18","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/alz.12433","article-title":"Diversity in Alzheimer's disease drug trials: the importance of eligibility criteria","volume":"18","author":"Franzen","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"7","key":"10.1016\/j.lanwpc.2025.101492_bib19","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/gps.2191","article-title":"Clinical and cost effectiveness of services for early diagnosis and intervention in dementia","volume":"24","author":"Banerjee","year":"2009","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101492_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1056\/NEJMra1510069","article-title":"The large pharmaceutical company perspective","volume":"376","author":"Rosenblatt","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.lanwpc.2025.101492_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017246","article-title":"Strategies for developing sustainable health research capacity in low and middle-income countries: a prospective, qualitative study investigating the barriers and enablers to locally led clinical trial conduct in Ethiopia, Cameroon and Sri Lanka","volume":"7","author":"Franzen","year":"2017","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.lanwpc.2025.101492_bib22","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-2800","article-title":"Stakeholder views of clinical trials in low- and middle-income countries: a systematic review","volume":"137","author":"Joseph","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.lanwpc.2025.101492_bib23","article-title":"Post-diagnosis dementia care in the Western Pacific region: assessment of needs and pathways to optimal care","volume":"50","author":"Jeon","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"issue":"7","key":"10.1016\/j.lanwpc.2025.101492_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271105","article-title":"A\u00a0direct comparison of patient-reported outcomes and experiences in alternative models of maternity care in Queensland, Australia","volume":"17","author":"Miller","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lanwpc.2025.101492_bib25","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1186\/s12877-022-03253-7","article-title":"Characterising Australian memory clinics: current practice and service needs informing national service guidelines","volume":"22","author":"Naismith","year":"2022","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.lanwpc.2025.101492_bib26","series-title":"Guaranteeing medicare and access to medicines \u2013 rural, regional and remote clinical trial enabling infrastructure program","year":"2020"},{"key":"10.1016\/j.lanwpc.2025.101492_bib27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-3-030-51140-1_8","article-title":"The frontotemporal dementia prevention initiative: linking together genetic frontotemporal dementia cohort studies","volume":"1281","author":"Rohrer","year":"2021","journal-title":"Adv Exp Med Biol"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266660652500029X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266660652500029X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T03:09:50Z","timestamp":1741489790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266660652500029X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":27,"alternative-id":["S266660652500029X"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2025.101492","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Holy Grail: highlighting the need for equitable access to dementia treatments and clinical trials","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2025.101492","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101492"}}